Upstate Active Clinical Trials

Study Title:

CALGB 90203:Randomized Phase III Study of Neo-adjuvant Docetaxel and Androgen Deprivation prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer

What is the purpose of the study?

The purpose of this study is to compare the effects (good and bad) of the combination of chemotherapy and hormone therapy followed by radical prostatectomy (surgery to remove the prostate) with radical prostatectomy alone on subjects and their prostate cancer to see which is better.This research is being done because many men with this type of prostate cancer are at risk of having the cancer come back if they are treated only with surgery. We are trying to find out if giving chemotherapy with hormone therapy before surgery makes the chance of being cured of prostate cancer better. We are also going to study whether anything in your diet or lifestyle predicts how well you do overall with your cancer.

Upstate Institutional Review Board (IRB) Number:

252321

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Bernard J Poiesz, MD

What is involved if I participate?

  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No

ClinicalTrials.Gov ID:

NCT00430183

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Diane M Gould
Phone: 315-464-8235
Email: gouldd@upstate.edu

Return to Previous Page || Search Again